Epigenetics of gastric cancer

Cancer Epigenetics: Risk Assessment, Diagnosis, Treatment, and Prognosis

Volumn , Issue , 2014, Pages 783-799

  Guo, Mingzhou ^a   Yan, Wenji ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Epigenetic; Gastric cancer; H. pylori; Histone modification; Hypermethylation; Hypomethylation; Long noncoding RNA; MicroRNA

Indexed keywords

EID: 84921788105     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4939-1804-1_41     Document Type: Chapter

References (148)

1. Jemal A, Bray F, Center MM (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
2. Hartgrink HH, Jansen EP, van Grieken NC et al (2009) Gastric cancer. Lancet 374:477-490
3. Ni C, Zhang Z, Zhu X et al (2013) Prognostic value of CD166 expression in cancers of the digestive system: a systematic review and metaanalysis. PLoS One 8:e70958
4. Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so- called intestinal-type carcinoma. an attempt at a histoclinical classification. Acta Pathol Microbiol Scand 64:31-49
5. Correa P, Haenszel W, Cuello C et al (1975) A model for gastric cancer epidemiology. Lancet 2:58-60
6. Humar B, Guilford P (2009) Hereditary diffuse gastric cancer: a manifestation of lost cell polarity. Cancer Sci 100:1151-1157
7. Carneiro F, Huntsman DG, Smyrk TC et al (2004) Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol 203:681-687
8. Tahara E (2004) Genetic pathways of two types of gastric cancer. IARC Sci Publ 157:327-349
9. Waddington CH (1939) Preliminary notes on the development of the wings in normal and mutant strains of Drosophila. Proc Natl Acad Sci U S A 25:299-307
10. Sadikovic B, Al-Romaih K, Squire JA et al (2008) Cause and consequences of genetic and epigenetic alterations in human cancer. Curr Genomics 9:394-408
11. Calcagno DQ, Gigek CO, Chen ES et al (2013) DNA and histone methylation in gastric carcinogenesis. World J Gastroenterol 19:1182-1192
12. Qu Y, Dang S, Hou P (2013) Gene methylation in gastric cancer. Clin Chim Acta 424:53-65
13. Jones PA, Takai D (2001) The role of DNA methylation in mammalian epigenetics. Science 293:1068-1070
14. Klose RJ, Bird AP (2006) Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31:89-97
15. Jia Y, Guo M (2013) Epigenetic changes in colorectal cancer. Chin J Cancer 32:21-30
16. Baylin SB, Ohm JE (2006) Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6:107-116
17. Kim H, Park J, Jung Y et al (2010) DNA methyltransferase 3-like affects promoter methylation of thymine DNA glycosylase independently of DNMT1 and DNMT3B in cancer cells. Int J Oncol 36:1563-1572
18. Yang J, Wei X, Wu Q et al (2011) Clinical significance of the expression of DNA methyltransferase proteins in gastric cancer. Mol Med Rep 4:1139-1143
19. Ding WJ, Fang JY, Chen XY et al (2008) The expression and clinical significance of DNA methyltransferase proteins in human gastric cancer. Dig Dis Sci 53:2083-2089
20. Chen ZX, Mann JR, Hsieh CL et al (2005) Physical and functional interactions between the human DNMT3L protein and members of the de novo methyltransferase family. J Cell Biochem 95:902-917
21. Feinberg AP, Vogelstein B (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301:89-92
22. Greger V, Passarge E, Hopping W et al (1989) Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum Genet 83:155-158
23. Sakai T, Toguchida J, Ohtani N et al (1991) Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet 48:880-888
24. Herman JG, Latif F, Weng Y et al (1994) Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A 91:9700-9704
25. Merlo A, Herman JG, Mao L et al (1995) 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1:686-692
26. Herman JG, Merlo A, Mao L et al (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55:4525-4530
27. Esteller M (2002) CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21:5427-5440
28. Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128:683-692
29. Sato F, Meltzer SJ (2006) CpG island hypermethylation in progression of esophageal and gastric cancer. Cancer 106:483-493
30. Tamura G (2006) Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol 12:192-198
31. Hu XT, He C (2013) Recent progress in the study of methylated tumor suppressor genes in gastric cancer. Chin J Cancer 32:31-41
32. Yang N, Zhang L, Zhang Y et al (2003) An important role for RUNX3 in human L1 transcription and retrotransposition. Nucleic Acids Res 31:4929-4940
33. Voon DC, Wang H, Koo JK et al (2012) Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity. Stem Cells 30:2088-2099
34. Yamamura Y, Lee WL, Inoue K et al (2006) RUNX3 cooperates with FoxO3a to induce apoptosis in gastric cancer cells. J Biol Chem 281:5267-5276
35. Chen W, Gao N, Shen Y et al (2010) Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer. J Gastroenterol Hepatol 25:823-831
36. Wang L, Chen S, Xue M et al (2012) Homeobox D10 gene, a candidate tumor suppressor, is downregulated through promoter hypermethylation and associated with gastric carcinogenesis. Mol Med 18:389-400
37. Yao D, Shi J, Shi B et al (2012) Quantitative assessment of gene methylation and their impact on clinical outcome in gastric cancer. Clin Chim Acta 413:787-794
38. Sugita H, Iida S, Inokuchi M et al (2011) Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer. Oncol Rep 25:513-518
39. Chen G, Cizeau J, Vande Velde C et al (1999) Nix and Nip3 form a subfamily of pro- apoptotic mitochondrial proteins. J Biol Chem 274:7-10
40. Kubasiak LA, Hernandez OM, Bishopric NH et al (2002) Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc Natl Acad Sci U S A 99:12825-12830
41. Murai M, Toyota M, Suzuki H et al (2005) Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer. Clin Cancer Res 11:1021-1027
42. Christofori G, Semb H (1999) The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 24:73-76
43. Tamura G, Yin J, Wang S et al (2000) E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 92:569-573
44. Yu QM, Wang XB, Luo J et al (2012) CDH1 methylation in preoperative peritoneal washes is an independent prognostic factor for gastric cancer. J Surg Oncol 106:765-771
45. Satoh A, Toyota M, Itoh F et al (2003) Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer. Cancer Res 63:8606-8613
46. Lander ES, Linton LM, Birren B et al (2001) Initial sequencing and analysis of the human genome. Nature 409:860-921
47. Howard G, Eiges R, Gaudet F et al (2008) Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice. Oncogene 27:404-408
48. Chen RZ, Pettersson U, Beard C et al (1998) DNA hypomethylation leads to elevated mutation rates. Nature 395:89-93
49. Eden A, Gaudet F, Waghmare A et al (2003) Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300:455
50. Shen L, Kondo Y, Guo Y et al (2007) Genomewide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS Genet 3:2023-2036
51. Hur K, Han TS, Jung EJ et al (2012) Up-regulated expression of sulfatases (SULF1 and SULF2) as prognostic and metastasis predictive markers in human gastric cancer. J Pathol 228:88-98
52. Shen J, Wei J, Wang H et al (2013) SULF2 methylation is associated with in vitro cisplatin sensitivity and clinical efficacy for gastric cancer patients treated with a modified FOLFOX regimen. PLoS One 8:e75564
53. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1994) Schistosomes, liver flukes and Helicobacter pylo. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 61:1-241
54. Correa P (1991) Is gastric carcinoma an infectious disease? N Engl J Med 325:1170-1171
55. Eslick GD, Lim LL, Byles JE et al (1999) Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 94:2373-2379
56. Uemura N, Okamoto S, Yamamoto S et al (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784-789
57. Ding SZ, Goldberg JB, Hatakeyama M (2010) Helicobacter pylori infection, oncogenic pathways and epigenetic mechanisms in gastric carcinogenesis. Future Oncol 6:851-862
58. Katayama Y, Takahashi M, Kuwayama H (2009) Helicobacter pylori causes runx3 gene methylation and its loss of expression in gastric epithelial cells, which is mediated by nitric oxide produced by macrophages. Biochem Biophys Res Commun 388:496-500
59. Chan AO, Lam SK, Wong BC et al (2003) Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 52:502-506
60. Ushijima T, Hattori N (2012) Molecular pathways:involvement of Helicobacter pyloritriggered inflammation in the formation of an epigenetic field defect, and its usefulness as cancer risk and exposure markers. Clin Cancer Res 18:923-929
61. Shin CM, Kim N, Jung Y et al (2011) Genomewide DNA methylation profiles in noncancerous gastric mucosae with regard to Helicobacter pylori infection and the presence of gastric cancer. Helicobacter 16:179-188
62. Cheng AS, Li MS, Kang W et al (2013) Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis. Gastroenterology 144:122-133e129
63. Ando T, Yoshida T, Enomoto S et al (2009) DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int J Cancer 124:2367-2374
64. Suzuki H, Yamamoto E, Nojima M et al (2010) Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Carcinogenesis 31:2066-2073
65. Miyazaki T, Murayama Y, Shinomura Y et al (2007) E-cadherin gene promoter hypermethylation in H. pylori-induced enlarged fold gastritis. Helicobacter 12:523-531
66. Nakajima T, Enomoto S, Yamashita S et al (2010) Persistence of a component of DNA methylation in gastric mucosae after Helicobacter pylori eradication. J Gastroenterol 45:37-44
67. Gigek CO, Chen ES, Calcagno DQ et al (2012) Epigenetic mechanisms in gastric cancer. Epigenomics 4:279-294
68. Kurdistani SK (2007) Histone modifications as markers of cancer prognosis: a cellular view. Br J Cancer 97:1-5
69. Martin C, Zhang Y (2005) The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 6:838-849
70. Zhang Y, Reinberg D (2001) Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev 15:2343-2360
71. Shilatifard A (2006) Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu Rev Biochem 75:243-269
72. Lan F, Shi Y (2009) Epigenetic regulation:methylation of histone and non-histone proteins. Sci China C Life Sci 52:311-322
73. Park YS, Jin MY, Kim YJ et al (2008) The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma. Ann Surg Oncol 15:1968-1976
74. Varambally S, Cao Q, Mani RS et al (2008) Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322:1695-1699
75. Fujii S, Ochiai A (2008) Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells. Cancer Sci 99:738-746
76. Coombes MM, Briggs KL, Bone JR et al (2003) Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation. Oncogene 22:8902-8911
77. Meng CF, Zhu XJ, Peng G et al (2010) Role of histone modifications and DNA methylation in the regulation of O6-methylguanine- DNA methyltransferase gene expression in human stomach cancer cells. Cancer Invest 28:331-339
78. Zhu WG, Dai Z, Ding H et al (2001) Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells. Oncogene 20:7787-7796
79. Liu J, Zhu X, Xu X et al (2014) DNA promoter and histone H3 methylation downregulate NGX6 in gastric cancer cells. Med Oncol 31:817
80. Yasui W, Oue N, Ono S et al (2003) Histone acetylation and gastrointestinal carcinogenesis. Ann N Y Acad Sci 983:220-231
81. Liu C, Xu D (2004) Inhibition of histone deacetylases. Methods Mol Biol 287:87-97
82. Wang GG, Allis CD, Chi P (2007) Chromatin remodeling and cancer, part I: covalent histone modifications. Trends Mol Med 13:363-372
83. Glozak MA, Sengupta N, Zhang X et al (2005) Acetylation and deacetylation of non- histone proteins. Gene 363:15-23
84. Ellis L, Atadja PW, Johnstone RW (2009) Epigenetics in cancer: targeting chromatin modifications. Mol Cancer Ther 8:1409-1420
85. Horwitz GA, Zhang K, McBrian MA et al (2008) Adenovirus small e1a alters global patterns of histone modification. Science 321:1084-1085
86. Ferrari R, Pellegrini M, Horwitz GA et al (2008) Epigenetic reprogramming by adenovirus e1a. Science 321:1086-1088
87. Bolden JE, Peart MJ, Johnstone RW (2006) Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 5:769-784
88. Sudo T, Mimori K, Nishida N et al (2011) Histone deacetylase 1 expression in gastric cancer. Oncol Rep 26:777-782
89. Song J, Noh JH, Lee JH et al (2005) Increased expression of histone deacetylase 2 is found in human gastric cancer. APMIS 113:264-268
90. Mutze K, Langer R, Becker K et al (2010) Histone deacetylase (HDAC) 1 and 2 expression and chemotherapy in gastric cancer. Ann Surg Oncol 17:3336-3343
91. Kim JK, Noh JH, Eun JW et al (2013) Targeted inactivation of HDAC2 restores p16INK4a activity and exerts antitumor effects on human gastric cancer. Mol Cancer Res 11:62-73
92. Yamamura N, Kishimoto T (2012) Epigenetic regulation of GATA4 expression by histone modification in AFP-producing gastric adenocarcinoma. Exp Mol Pathol 93:35-39
93. Mitani Y, Oue N, Hamai Y et al (2005) Histone H3 acetylation is associated with reduced p21(WAF1/CIP1) expression by gastric carcinoma. J Pathol 205:65-73
94. Lee JH, Song MY, Song EK et al (2009) Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes 58:344-351
95. Sun WJ, Zhou X, Zheng JH et al (2012) Histone acetyltransferases and deacetylases:molecular and clinical implications to gastrointestinal carcinogenesis. Acta Biochim Biophys Sin (Shanghai) 44:80-91
96. Bannister AJ, Kouzarides T (2011) Regulation of chromatin by histone modifications. Cell Res 21:381-395
97. Oki M, Aihara H, Ito T (2007) Role of histone phosphorylation in chromatin dynamics and its implications in diseases. Subcell Biochem 41:319-336
98. Takahashi H, Murai Y, Tsuneyama K et al (2006) Overexpression of phosphorylated histone H3 is an indicator of poor prognosis in gastric adenocarcinoma patients. Appl Immunohistochem Mol Morphol 14:296-302
99. Hershko A, Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67:425-479
100. Wang H, Wang L, Erdjument-Bromage H et al (2004) Role of histone H2A ubiquitination in polycomb silencing. Nature 431:873-878
101. Kouzarides T (2007) Chromatin modifications and their function. Cell 128:693-705
102. Seeler JS, Dejean A (2003) Nuclear and unclear functions of SUMO. Nat Rev Mol Cell Biol 4:690-699
103. Esteller M (2011) Non-coding RNAs in human disease. Nat Rev Genet 12:861-874
104. Mercer TR, Dinger ME, Mattick JS (2009) Long non-coding RNAs: insights into functions. Nat Rev Genet 10:155-159
105. Babashah S, Soleimani M (2011) The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis. Eur J Cancer 47:1127-1137
106. Carthew RW, Sontheimer EJ (2009) Origins and mechanisms of miRNAs and siRNAs. Cell 136:642-655
107. Friedman RC, Farh KK, Burge CB et al (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19:92-105
108. Volinia S, Calin GA, Liu CG et al (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103:2257-2261
109. Ferracin M, Pedriali M, Veronese A et al (2011) MicroRNA profiling for the identification of cancers with unknown primary tissueof- origin. J Pathol 225:43-53
110. Tsujiura M, Ichikawa D, Komatsu S et al (2010) Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 102:1174-1179
111. Liu H, Zhu L, Liu B et al (2012) Genomewide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett 316:196-203
112. Liu R, Zhang C, Hu Z et al (2011) A fivemicroRNA signature identified from genomewide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer 47:784-791
113. Consortium EP, Birney E, Stamatoyannopoulos JA et al (2007) Identification and analysis of functional elements in 1 % of the human genome by the ENCODE pilot project. Nature 447:799-816
114. Guttman M, Amit I, Garber M et al (2009) Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458:223-227
115. Nagano T, Fraser P (2011) No-nonsense functions for long noncoding RNAs. Cell 145:178-181
116. Ponting CP, Oliver PL, Reik W (2009) Evolution and functions of long noncoding RNAs. Cell 136:629-641
117. Louro R, Smirnova AS, Verjovski-Almeida S (2009) Long intronic noncoding RNA transcription:expression noise or expression choice? Genomics 93:291-298
118. Wilusz JE, Sunwoo H, Spector DL (2009) Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 23:1494-1504
119. Sana J, Faltejskova P, Svoboda M et al (2012) Novel classes of non-coding RNAs and cancer. J Transl Med 10:103
120. Mattick JS, Amaral PP, Dinger ME et al (2009) RNA regulation of epigenetic processes. Bioessays 31:51-59
121. Wang KC, Chang HY (2011) Molecular mechanisms of long noncoding RNAs. Mol Cell 43:904-914
122. Sun M, Xia R, Jin F et al (2013) Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumour Biol 35(2):1065-1073
123. Endo H, Shiroki T, Nakagawa T et al (2013) Enhanced expression of long non-coding RNA HOTAIR is associated with the development of gastric cancer. PLoS One 8:e77070
124. Zhao Y, Guo Q, Chen J et al (2014) Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation. Oncol Rep 31:358-364
125. Yu J, Tao Q, Cheung KF et al (2008) Epigenetic identification of ubiquitin carboxylterminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. Hepatology 48:508-518
126. Du W, Wang S, Zhou Q et al (2013) ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer. Oncogene 32:3319-3328
127. Alvarez MC, Santos JC, Maniezzo N et al (2013) MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults. World J Gastroenterol 19:3043-3051
128. Akiyama Y, Watkins N, Suzuki H et al (2003) GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol Cell Biol 23:8429-8439
129. Wen XZ, Akiyama Y, Pan KF et al (2010) Methylation of GATA-4 and GATA-5 and development of sporadic gastric carcinomas. World J Gastroenterol 16:1201-1208
130. Yu J, Cheng YY, Tao Q et al (2009) Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. Gastroenterology 136:640-651 e641
131. Xu L, Li X, Chu ES et al (2012) Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival. Gut 61:977-985
132. Agathanggelou A, Cooper WN, Latif F (2005) Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 65:3497-3508
133. Shi DT, Han M, Gao N et al (2013) Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis. Tumour Biol 35(2):943-948
134. Kim SJ, Hwang JA, Ro JY et al (2013) Galectin-7 is epigenetically-regulated tumor suppressor in gastric cancer. Oncotarget 4:1461-1471
135. Ivanova T, Zouridis H, Wu Y et al (2013) Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer. Gut 62:22-33
136. Miao R, Guo X, Zhi Q et al (2013) VEZT, a novel putative tumor suppressor, suppresses the growth and tumorigenicity of gastric cancer. PLoS One 8:e74409
137. Hashiguchi Y, Nishida N, Mimori K et al (2012) Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance. Int J Oncol 40:1477-1482
138. Wang HJ, Ruan HJ, He XJ et al (2010) MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur J Cancer 46:2295-2303
139. Zhu A, Xia J, Zuo J et al (2012) MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer. Med Oncol 29:2701-2709
140. Zuo J, Xia J, Ju F et al (2013) MicroRNA-148a can regulate runt-related transcription factor 3 gene expression via modulation of DNA methyltransferase 1 in gastric cancer. Mol Cells 35:313-319
141. Song YX, Yue ZY, Wang ZN et al (2011) MicroRNA-148b is frequently downregulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Mol Cancer 10:1
142. Sun T, Wang C, Xing J et al (2011) miR-429 modulates the expression of c-myc in human gastric carcinoma cells. Eur J Cancer 47:2552-2559
143. Lai KW, Koh KX, Loh M et al (2010) MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer. Eur J Cancer 46:1456-1463
144. Tang H, Deng M, Tang Y et al (2013) MiR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression. Clin Cancer Res 19:5602-5612
145. Zhang BG, Li JF, Yu BQ et al (2012) microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep 27:1019-1026
146. Jin Z, Selaru FM, Cheng Y et al (2011) MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. Oncogene 30:1577-1585
147. Brenner B, Hoshen MB, Purim O et al (2011) MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol 17:3976-3985
148. Xiao B, Zhu ED, Li N et al (2012) Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis. Oncol Rep 27:559-566